CytomX Therapeutics, Inc.

NASDAQ:CTMX

1 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013
Assets:
Current Assets:
Cash & Cash Equivalents 17.171193.65205.53191.859188.425247.577177.548104.64559.82264.3968.703
Short Term Investments 157.338099.696124.26107.72188.55196.56277.293126.88900
Cash and Short Term Investments 174.509193.65305.226316.119296.145436.127374.11181.938186.71164.3968.703
Net Receivables 3.43235.9860.790.7980.0130.09710.1392.3130.7441.8750.237
Inventory 0000000000.10.1
Other Current Assets 4.9957.4664.2857.0967.1779.2514.3523.8962.2990.4820.226
Total Current Assets 182.936237.102310.301324.013303.335445.475388.601188.147189.75466.8539.266
Non-Current Assets:
Property, Plant & Equipment, Net 16.17821.02125.32229.44532.7546.9344.2184.3923.4813.0182.07
Goodwill 0.9490.9490.9490.9490.9490.9490.9490.9490.9490.9490.949
Intangible Assets 0.7290.8751.0211.1671.3121.4581.6041.751.751.751.75
Goodwill and Intangible Assets 1.6781.8241.972.1162.2612.4072.5532.6992.6992.6992.699
Long Term Investments 0.9170.9170.9170.9170.9170.9170.9170.9170.99500
Tax Assets 3.3593.5954.615.542-0.9171.1370.3980.3110.40100
Other Non-Current Assets 0.083-3.568-3.709-3.372.9320.2380.9572.662-0.1150.4920.148
Total Non-Current Assets 22.21523.78929.1134.6537.94711.6339.04310.9817.4616.2094.917
Total Assets 205.151260.891339.411358.663341.282457.108397.644199.128197.21573.06214.183
Liabilities & Equity:
Current Liabilities:
Account Payables 1.4582.8092.8182.9964.1585.1324.2056.5964.6971.9190.93
Short Term Debt 4.5894.0823.6183.1952.8113.3390001.4191.258
Tax Payables 0000013.33900000
Deferred Revenue 132.267121.26769.26274.86951.38152.71340.55920.3476.136.130.857
Other Current Liabilities 17.59924.4530.61819.86427.24126.72416.3838.8244.9121.6951.127
Total Current Liabilities 155.913152.608106.316100.92485.5997.90861.14735.76715.73911.1634.172
Non-Current Liabilities:
Long Term Debt 9.38513.97518.05621.67524.871-1.137-0.398001.5682.945
Deferred Revenue Non-Current 80.048180.059125.66186.261178.858225.267264.70483.80354.70360.8334.643
Deferred Tax Liabilities Non-Current 3.3593.5954.615.54201.1370.3980.5130.5070.4990.491
Other Non-Current Liabilities 3.893-3.595-4.61-5.5420.853.051.8970.5660.19877.5446.211
Total Non-Current Liabilities 96.685194.034143.716207.936204.579228.317266.60184.88255.408140.4454.29
Total Liabilities 252.598346.642250.032308.86290.169326.225327.748120.64971.147151.60358.462
Equity:
Preferred Stock 00000457.108397.644199.128197.21576.89644.862
Common Stock 0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Retained Earnings -723.448-722.879-533.724-450.115-417.23-314.981-219.465-176.366-117.466-78.138-43.881
Accumulated Other Comprehensive Income/Loss 0.0950.01-0.242-0.0470.057-0.093-0.094-0.027-0.076-0.404-0.399
Other Total Stockholders Equity 675.905637.117623.344499.964468.285-11.152-108.1955.74346.394-76.896-44.862
Total Shareholders Equity -47.447-85.75189.37949.80351.113130.88369.89678.479126.068-78.541-44.279
Total Equity -47.447-85.75189.37949.80351.113130.88369.89678.479126.068-78.541-44.279
Total Liabilities & Shareholders Equity 205.151260.891339.411358.663341.282457.108397.644199.128197.21573.06214.183